Performance of the Colloidal Gold Immunochromatography of Cryptococcal Antigen on Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Cryptococcosis
- PMID: 35855856
- PMCID: PMC9288310
- DOI: 10.1155/2022/7876030
Performance of the Colloidal Gold Immunochromatography of Cryptococcal Antigen on Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Cryptococcosis
Abstract
Objective: This study aimed to investigate the efficacy of the colloidal gold immunochromatography method in the detection of Cryptococcus antigen in bronchoalveolar lavage fluid (BALF) for pulmonary cryptococcosis (PC) diagnosis.
Methods: A total of 111 patients with clinically suspected PC who were finally diagnosed with nonhuman immunodeficiency virus infection and hospitalized in the Ningbo First Hospital from March 2017 to December 2021 were retrospectively analyzed. All the confirmed cases were divided into two groups as follows: the PC group (33 cases) and the non-PC group (78 cases). All the patients were subjected to serum and BALF cryptococcal capsular polysaccharide antigen-lateral flow immunochromatographic assay (CrAg-LFA) and etiological culturing.
Results: In the PC group, serum CrAg-LFA was positive for 24 and negative for 9 cases, serum Cryptococcus culture was positive for 1 and negative for 32 cases, BALF CrAg-LFA was positive for 31 and negative for 2 cases, and BALF Cryptococcus culture was positive for 9 and negative for 24 cases. In the non-PC group, serum CrAg-LFA was positive for 1 and negative for 77 cases, serum culture was negative in all the cases, and both BALF CrAg-LFA and culture were negative in all the cases. The sensitivity, specificity, and accuracy of BALF CrAg-LFA for PC diagnosis were 93.9%, 100%, and 98.2%, respectively, whereas those of BALF culture were 27.3%, 100%, and 78.4%, respectively. The sensitivity and accuracy of BALF CrAg-LFA were higher than that of serum CrAg-LFA and BALF etiological culture with statistically significant differences (p < 0.05).
Conclusion: The diagnostic value of BALF CrAg-LFA for PC is superior to that of serum CrAg-LFA and BALF etiological culture.
Copyright © 2022 Ning Zhu et al.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Similar articles
-
Diagnostic value of bronchoalveolar lavage fluid cryptococcal antigen-lateral flow immunochromatographic assay for pulmonary cryptococcosis in non-HIV patients.Diagn Microbiol Infect Dis. 2021 Mar;99(3):115276. doi: 10.1016/j.diagmicrobio.2020.115276. Epub 2020 Nov 26. Diagn Microbiol Infect Dis. 2021. PMID: 33341492
-
[Diagnostic value of the combinations of bronchoalveolar lavage fluid pathogen detection and cryptococcal antigen test in pulmonary cryptococcosis].Zhonghua Jie He He Hu Xi Za Zhi. 2021 Aug 12;44(8):711-716. doi: 10.3760/cma.j.cn112147-20201123-01113. Zhonghua Jie He He Hu Xi Za Zhi. 2021. PMID: 34645137 Chinese.
-
Low Cryptococcus Antigen Titers as Determined by Lateral Flow Assay Should Be Interpreted Cautiously in Patients without Prior Diagnosis of Cryptococcal Infection.J Clin Microbiol. 2017 Aug;55(8):2472-2479. doi: 10.1128/JCM.00751-17. Epub 2017 May 31. J Clin Microbiol. 2017. PMID: 28566315 Free PMC article.
-
Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review.BMC Infect Dis. 2023 Apr 6;23(1):209. doi: 10.1186/s12879-023-08135-w. BMC Infect Dis. 2023. PMID: 37024842 Free PMC article.
-
Cryptococcal antigen detection in broncho-alveolar lavage fluid.Med Mycol. 2018 Aug 1;56(6):774-777. doi: 10.1093/mmy/myx092. Med Mycol. 2018. PMID: 29087508 Review.
Cited by
-
Pulmonary cryptococcosis in non-HIV-infected individuals: HRCT characteristics in 58 patients.Medicine (Baltimore). 2024 Jun 28;103(26):e38671. doi: 10.1097/MD.0000000000038671. Medicine (Baltimore). 2024. PMID: 38941424 Free PMC article.
-
Commentary: Comparison of different therapeutic approaches for pulmonary cryptococcosis in kidney transplant recipients: a 15-year retrospective analysis.Front Med (Lausanne). 2023 Oct 17;10:1275042. doi: 10.3389/fmed.2023.1275042. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37920600 Free PMC article. No abstract available.
-
Clinicopathological Analysis of 60 Cases of Pulmonary Cryptococcosis.Int J Gen Med. 2025 Jun 17;18:3207-3214. doi: 10.2147/IJGM.S525789. eCollection 2025. Int J Gen Med. 2025. PMID: 40547348 Free PMC article.
-
Metagenomic next-generation sequencing contributes to the diagnosis of mixed pulmonary infection: a case report.Ann Clin Microbiol Antimicrob. 2022 Nov 24;21(1):52. doi: 10.1186/s12941-022-00545-z. Ann Clin Microbiol Antimicrob. 2022. PMID: 36434704 Free PMC article.
References
-
- Jenks J. D., Mehta S. R., Taplitz R., Aslam S., Reed S. L., Hoenigl M. Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus ‐specific Lateral Flow Device test in bronchoalveolar lavage. Mycoses . 2019;62(3):230–236. doi: 10.1111/myc.12881. - DOI - PMC - PubMed
-
- De Pauw B., Walsh T., Donnelly J., et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clinical Infectious Diseases . 2008;46(12):1813–1821. doi: 10.1086/588660. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources